The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy
Joint Authors
Rong, Fangning
Ji, Kangting
Weng, Yingpei
Peng, Yangpei
Source
Cardiology Research and Practice
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-12-16
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Immune checkpoint inhibitors (ICIs) therapy has recently been introduced to all kinds of cancers.
The adverse reactions associated with this therapy have attracted much attention.
The heart-related adverse reactions are mainly the immune-related myocarditis and heart failure.
Cases of adverse cardiac reactions caused by ICIs therapy have been clearly reported.
However, the pathogenesis of the adverse cardiac reactions remains unclear.
Therefore, this article briefly reviews the mechanism and management of adverse cardiac reactions caused by ICIs therapy.
American Psychological Association (APA)
Rong, Fangning& Ji, Kangting& Weng, Yingpei& Peng, Yangpei. 2020. The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy. Cardiology Research and Practice،Vol. 2020, no. 2020, pp.1-5.
https://search.emarefa.net/detail/BIM-1152614
Modern Language Association (MLA)
Rong, Fangning…[et al.]. The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy. Cardiology Research and Practice No. 2020 (2020), pp.1-5.
https://search.emarefa.net/detail/BIM-1152614
American Medical Association (AMA)
Rong, Fangning& Ji, Kangting& Weng, Yingpei& Peng, Yangpei. The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy. Cardiology Research and Practice. 2020. Vol. 2020, no. 2020, pp.1-5.
https://search.emarefa.net/detail/BIM-1152614
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1152614